These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 1701961

  • 1. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
    Meissner K, Rivière A, Haupt G, Löning T.
    Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
    [Abstract] [Full Text] [Related]

  • 2. HER-2/neu expression in Paget disease of the vulva and the female breast.
    Brummer O, Stegner HE, Böhmer G, Kühnle H, Petry KU.
    Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
    [Abstract] [Full Text] [Related]

  • 3. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
    Edorh A, Parache RM, Migeon C, N'Sossani B, Rihn B.
    Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
    [Abstract] [Full Text] [Related]

  • 4. Expression of ras p21 in mammary and extramammary Paget's disease.
    Mori O, Hachisuka H, Nakano S, Sasai Y, Shiku H.
    Arch Pathol Lab Med; 1990 Aug; 114(8):858-61. PubMed ID: 1695839
    [Abstract] [Full Text] [Related]

  • 5. HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study.
    Bianco MK, Vasef MA.
    Diagn Mol Pathol; 2006 Sep; 15(3):131-5. PubMed ID: 16932067
    [Abstract] [Full Text] [Related]

  • 6. [An immunohistochemical analysis of extramammary Paget's disease compared with mammary Paget's disease].
    Hasebe T, Yamamichi N, Konishi F, Mukawa A.
    Gan No Rinsho; 1988 Feb; 34(2):159-66. PubMed ID: 2831411
    [Abstract] [Full Text] [Related]

  • 7. COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study.
    Horn LC, Purz S, Krumpe C, Bilek K.
    Arch Gynecol Obstet; 2008 Feb; 277(2):135-8. PubMed ID: 17701193
    [Abstract] [Full Text] [Related]

  • 8. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
    Ellis PE, Wong Te Fong LF, Rolfe KJ, Crow JC, Reid WM, Davidson T, MacLean AB, Perret CW.
    Anticancer Res; 2002 Feb; 22(2A):857-61. PubMed ID: 12014662
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical studies of breast and extra-mammary Paget's disease indicate an apocrine differentiation].
    Lautier R, Achtelik WV, Wolff HH.
    Z Hautkr; 1990 Jun; 65(6):571-4. PubMed ID: 2167569
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin 7 staining in mammary and extramammary Paget's disease.
    Smith KJ, Tuur S, Corvette D, Lupton GP, Skelton HG.
    Mod Pathol; 1997 Nov; 10(11):1069-74. PubMed ID: 9388055
    [Abstract] [Full Text] [Related]

  • 11. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 12. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
    Keatings L, Sinclair J, Wright C, Corbett IP, Watchorn C, Hennessy C, Angus B, Lennard T, Horne CH.
    Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
    [Abstract] [Full Text] [Related]

  • 13. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease.
    Wolber RA, Dupuis BA, Wick MR.
    Am J Clin Pathol; 1991 Aug; 96(2):243-7. PubMed ID: 1713741
    [Abstract] [Full Text] [Related]

  • 14. [Associated Paget's disease of the vulva and of the nipple in the same patient: pathology with ultrastructural study (author's transl)].
    Fetissoff F, Arbeille-Brassart B, Lansac J, Sam-Giao M, Granger M, Lorette G.
    Ann Dermatol Venereol; 1982 Aug; 109(1):43-50. PubMed ID: 6280570
    [Abstract] [Full Text] [Related]

  • 15. Claudin expression in breast tumors.
    Kulka J, Tökés AM.
    Hum Pathol; 2005 Jul; 36(7):859; author reply 860. PubMed ID: 16084960
    [No Abstract] [Full Text] [Related]

  • 16. Mammary and extramammary Paget's disease. An immunocytochemical study.
    Bussolati G, Pich A.
    Am J Pathol; 1975 Jul; 80(1):117-28. PubMed ID: 168778
    [Abstract] [Full Text] [Related]

  • 17. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.
    Liegl B, Leibl S, Gogg-Kamerer M, Tessaro B, Horn LC, Moinfar F.
    Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019
    [Abstract] [Full Text] [Related]

  • 18. Toker-cell pathology as a unifying concept.
    Fernandez-Flores A.
    Histopathology; 2008 Jun; 52(7):889-91; author reply 891-2. PubMed ID: 18462365
    [No Abstract] [Full Text] [Related]

  • 19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF, Maguire HC, Greene MI, Weiner DB, LiVolsi VA.
    Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.